NASDAQ: AVDL
Avadel Pharmaceuticals PLC Stock Ownership - Who owns Avadel Pharmaceuticals?

Insider buying vs selling

Have Avadel Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Linda PalczukDirector2025-01-215,000$7.93
$39.64kBuy
Peter J. ThorntonDirector2025-01-1310,000$8.05
$80.45kBuy
Eric J. EndeDirector2025-01-1330,000$7.84
$235.23kBuy
Thomas S. McHughChief Financial Officer2024-12-132,300$10.44
$24.02kBuy
Thomas S. McHughChief Financial Officer2024-12-115,000$10.49
$52.43kBuy
Geoffrey Michael GlassDirector2024-12-1010,204$9.80
$100.00kBuy
Geoffrey Michael GlassDirector2024-12-1010,075$9.89
$99.64kBuy
Gregory J. DivisChief Executive Officer2024-12-09402$9.82
$3.95kBuy
Gregory J. DivisChief Executive Officer2024-12-069,598$9.98
$95.76kBuy
Linda PalczukDirector2024-12-063,000$10.19
$30.57kBuy

1 of 1

AVDL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVDL insiders and whales buy or sell their stock.

AVDL Shareholders

What type of owners hold Avadel Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC14.57%14,080,219$113.06MInstitution
Gendell Jeffrey L6.55%6,330,435$50.83MInstitution
Blackrock Inc5.63%5,439,408$43.68MInstitution
Polar Capital Holdings PLC4.57%4,414,200$35.45MInstitution
Two Seas Capital LP4.45%4,296,449$34.50MInstitution
Broadfin Healthcare Master Fund Ltd4.28%4,133,464$33.19MInsider
Braidwell LP4.25%4,105,726$32.97MInstitution
Vanguard Group Inc4.09%3,953,247$31.74MInstitution
James E. Flynn3.80%3,674,506$29.51MInsider
Kevin Kotler3.24%3,130,573$25.14MInsider

1 of 3

AVDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVDL82.18%13.63%Net Buying
HROW28.51%71.49%Net SellingNet Selling
COLL57.13%42.87%Net SellingNet Selling
PAHC45.01%54.99%Net BuyingNet Buying
CRON11.34%49.08%Net SellingNet Selling

Avadel Pharmaceuticals Stock Ownership FAQ

Who owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals (NASDAQ: AVDL) is owned by 82.18% institutional shareholders, 13.63% Avadel Pharmaceuticals insiders, and 4.19% retail investors. Broadfin Healthcare Master Fund Ltd is the largest individual Avadel Pharmaceuticals shareholder, owning 4.13M shares representing 4.28% of the company. Broadfin Healthcare Master Fund Ltd's Avadel Pharmaceuticals shares are currently valued at $32.90M.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.